
AVAC recently launched Px Wire, which will track key developments in the field of HIV prevention research, including the launch of new trials, results of ongoing studies, and an up-to-date tally of trials going on worldwide.
Px Wire is designed to complement AVAC's other publications and to help advocates stay on top of the ever-changing field of HIV prevention research. It is the first one-stop source for information on the full range of HIV prevention research going on worldwide, including vaccines, microbicides, pre-exposure prophylaxis (PrEP), herpes simplex virus-2 treatment, male circumcision, cervical barrier methods, and partner treatment.
Every three months, Px Wire will provide:
* A center foldout poster with:
o An updated comprehensive timeline of efficacy trials of new biomedical HIV prevention trials worldwide
o A world map showing where various strategies are being tested
* A tally of experimental prevention strategies in all phases of clinical development
* Brief news bulletins and "AVAC's take" on current events
* A calendar of upcoming meetings
The first issue is available. Additional resources including the Px Wire archive, information about subscribing, reprint requests and bulk orders can be found here.
No comments:
Post a Comment